{"id":"https://openalex.org/W3213062408","doi":"https://doi.org/10.1093/ijnp/pyab071","title":"A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia","display_name":"A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia","publication_year":2021,"publication_date":"2021-11-10","ids":{"openalex":"https://openalex.org/W3213062408","doi":"https://doi.org/10.1093/ijnp/pyab071","mag":"3213062408","pmid":"https://pubmed.ncbi.nlm.nih.gov/34791283","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8929757"},"language":"en","primary_location":{"id":"doi:10.1093/ijnp/pyab071","doi":"https://doi.org/10.1093/ijnp/pyab071","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ijnp/pyab071","pdf_url":null,"source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Neuropsychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1093/ijnp/pyab071","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064130565","display_name":"Dean M. Najarian","orcid":"https://orcid.org/0000-0002-2556-2144","observed_orcids":["https://orcid.org/0000-0002-2556-2144"]},"institutions":[{"id":"https://openalex.org/I4391767992","display_name":"Janssen Scientific Affairs (United States)","ror":"https://ror.org/04w4xsz15","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4391767992"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Dean Najarian","raw_affiliation_strings":["Janssen Scientific Affairs, LLC, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Scientific Affairs, LLC, New Jersey, USA","institution_ids":["https://openalex.org/I4391767992"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021973179","display_name":"Panna Sanga","orcid":"https://orcid.org/0000-0003-0903-2925","observed_orcids":["https://orcid.org/0000-0003-0903-2925"]},"institutions":[{"id":"https://openalex.org/I4210151386","display_name":"Janssen (United States)","ror":"https://ror.org/05af73403","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210151386"]},{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Panna Sanga","raw_affiliation_strings":["Janssen Research and Development LLC, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research and Development LLC, New Jersey, USA","institution_ids":["https://openalex.org/I4210151386","https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101707020","display_name":"Steven Wang","orcid":"https://orcid.org/0000-0001-7763-6005","observed_orcids":["https://orcid.org/0000-0001-7763-6005"]},"institutions":[{"id":"https://openalex.org/I4210151386","display_name":"Janssen (United States)","ror":"https://ror.org/05af73403","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210151386"]},{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Wang","raw_affiliation_strings":["Janssen Research and Development LLC, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research and Development LLC, New Jersey, USA","institution_ids":["https://openalex.org/I4210151386","https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091766408","display_name":"Pilar Lim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151386","display_name":"Janssen (United States)","ror":"https://ror.org/05af73403","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210151386"]},{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pilar Lim","raw_affiliation_strings":["Janssen Research and Development LLC, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research and Development LLC, New Jersey, USA","institution_ids":["https://openalex.org/I4210151386","https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011875552","display_name":"Arun Singh","orcid":"https://orcid.org/0000-0002-9567-6139","observed_orcids":["https://orcid.org/0000-0002-9567-6139"]},"institutions":[{"id":"https://openalex.org/I4210151386","display_name":"Janssen (United States)","ror":"https://ror.org/05af73403","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210151386"]},{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arun Singh","raw_affiliation_strings":["Janssen Research and Development LLC, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research and Development LLC, New Jersey, USA","institution_ids":["https://openalex.org/I4210151386","https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109304740","display_name":"Mary Jane Robertson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151386","display_name":"Janssen (United States)","ror":"https://ror.org/05af73403","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210151386"]},{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary Jane Robertson","raw_affiliation_strings":["Janssen Research and Development LLC, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research and Development LLC, New Jersey, USA","institution_ids":["https://openalex.org/I4210151386","https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104011135","display_name":"Kristin Cohen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151386","display_name":"Janssen (United States)","ror":"https://ror.org/05af73403","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210151386"]},{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristin Cohen","raw_affiliation_strings":["Janssen Research and Development LLC, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research and Development LLC, New Jersey, USA","institution_ids":["https://openalex.org/I4210151386","https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113650870","display_name":"Alain Schotte","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Alain Schotte","raw_affiliation_strings":["Janssen Research and Development, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research and Development, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004709278","display_name":"Ruth Milz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128934","display_name":"Janssen (Germany)","ror":"https://ror.org/038rd9v60","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210128934"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ruth Milz","raw_affiliation_strings":["Janssen-Cilag, Neuss, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen-Cilag, Neuss, Germany","institution_ids":["https://openalex.org/I4210128934"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059294813","display_name":"Raja Venkatasubramanian","orcid":"https://orcid.org/0000-0003-2764-0254","observed_orcids":["https://orcid.org/0000-0003-2764-0254"]},"institutions":[{"id":"https://openalex.org/I4210151386","display_name":"Janssen (United States)","ror":"https://ror.org/05af73403","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210151386"]},{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raja Venkatasubramanian","raw_affiliation_strings":["Janssen Research and Development LLC, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research and Development LLC, New Jersey, USA","institution_ids":["https://openalex.org/I4210151386","https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047994447","display_name":"Huybrecht T\u2019jollyn","orcid":"https://orcid.org/0000-0003-2101-9926","observed_orcids":["https://orcid.org/0000-0003-2101-9926"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Huybrecht T\u2019Jollyn","raw_affiliation_strings":["Janssen Research and Development, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research and Development, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046162184","display_name":"David P. Walling","orcid":"https://orcid.org/0000-0001-8638-2086","observed_orcids":["https://orcid.org/0000-0001-8638-2086"]},"institutions":[{"id":"https://openalex.org/I4210129757","display_name":"Collaborative Neuroscience Network","ror":"https://ror.org/034a8v770","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210129757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David P Walling","raw_affiliation_strings":["CNS Network, LLC, Garden Grove, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNS Network, LLC, Garden Grove, California, USA","institution_ids":["https://openalex.org/I4210129757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032931781","display_name":"Silvana Galderisi","orcid":"https://orcid.org/0000-0002-1592-7656","observed_orcids":["https://orcid.org/0000-0002-1592-7656"]},"institutions":[{"id":"https://openalex.org/I197809005","display_name":"University of Campania \"Luigi Vanvitelli\"","ror":"https://ror.org/02kqnpp86","country_code":"IT","type":"education","lineage":["https://openalex.org/I197809005"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Silvana Galderisi","raw_affiliation_strings":["University of Campania \u201cLuigi Vanvitelli,\u201d Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Campania \u201cLuigi Vanvitelli,\u201d Naples, Italy","institution_ids":["https://openalex.org/I197809005"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076376973","display_name":"Srihari Gopal","orcid":"https://orcid.org/0000-0001-5254-2192","observed_orcids":["https://orcid.org/0000-0001-5254-2192"]},"institutions":[{"id":"https://openalex.org/I4210151386","display_name":"Janssen (United States)","ror":"https://ror.org/05af73403","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210151386"]},{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Srihari Gopal","raw_affiliation_strings":["Janssen Research and Development LLC, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research and Development LLC, New Jersey, USA","institution_ids":["https://openalex.org/I4210151386","https://openalex.org/I4405282460"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5064130565"],"corresponding_institution_ids":["https://openalex.org/I4391767992"],"apc_list":{"value":1610,"currency":"GBP","value_usd":2530},"apc_paid":{"value":1610,"currency":"GBP","value_usd":2530},"fwci":7.4735,"has_fulltext":false,"cited_by_count":68,"citation_normalized_percentile":{"value":0.98374886,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"25","issue":"3","first_page":"238","last_page":"251"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12980","display_name":"Family Caregiving in Mental Illness","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paliperidone-palmitate","display_name":"paliperidone palmitate","score":0.9509999752044678},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.6539999842643738},{"id":"https://openalex.org/keywords/long-acting-injectable-antipsychotics","display_name":"long-acting injectable antipsychotics","score":0.9819999933242798},{"id":"https://openalex.org/keywords/non-inferiority","display_name":"non-inferiority","score":0.7250000238418579},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.8159999847412109},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.8149999976158142},{"id":"https://openalex.org/keywords/antipsychotic-efficacy-and-safety","display_name":"antipsychotic efficacy and safety","score":0.7089999914169312},{"id":"https://openalex.org/keywords/maintenance-phase","display_name":"maintenance phase","score":0.33000001311302185},{"id":"https://openalex.org/keywords/gluteal-injection","display_name":"gluteal injection","score":0.6309999823570251},{"id":"https://openalex.org/keywords/extended-release-formulation","display_name":"sustained-release formulation","score":0.3400000035762787},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.6949999928474426},{"id":"https://openalex.org/keywords/antipsychotic-switching","display_name":"antipsychotic switching","score":0.37700000405311584}],"concepts":[{"id":"https://openalex.org/C2908997079","wikidata":"https://www.wikidata.org/wiki/Q27157250","display_name":"Paliperidone Palmitate","level":4,"score":0.9705920219421387},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7749963998794556},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.622752845287323},{"id":"https://openalex.org/C2777126507","wikidata":"https://www.wikidata.org/wiki/Q423292","display_name":"Paliperidone","level":4,"score":0.6131888031959534},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6078979969024658},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5820046067237854},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5263099670410156},{"id":"https://openalex.org/C3020385749","wikidata":"https://www.wikidata.org/wiki/Q5165929","display_name":"Extended release","level":2,"score":0.5233606100082397},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.48365676403045654},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48048439621925354},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.3893621861934662},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3414011001586914},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.22061991691589355},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.16948345303535461},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.10991710424423218}],"mesh":[{"descriptor_ui":"D000068882","descriptor_name":"Paliperidone Palmitate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1093/ijnp/pyab071","doi":"https://doi.org/10.1093/ijnp/pyab071","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ijnp/pyab071","pdf_url":null,"source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Neuropsychopharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8929757","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8929757","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int J Neuropsychopharmacol","raw_type":"Text"},{"id":"pmid:34791283","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34791283","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The international journal of neuropsychopharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:iris.unicampania.it:11591/469919","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11591/469919","pdf_url":null,"source":{"id":"https://openalex.org/S7407055255","display_name":"Archivio Istituzionale della Ricerca - Universit\u00e0 degli Studi della Campania \"Luigi Vanvitelli\"","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1093/ijnp/pyab071","doi":"https://doi.org/10.1093/ijnp/pyab071","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ijnp/pyab071","pdf_url":null,"source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Neuropsychopharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320337415","display_name":"Janssen Research and Development","ror":"https://ror.org/03qd7mz70"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W1151536748","https://openalex.org/W1742833546","https://openalex.org/W1763953748","https://openalex.org/W1973562905","https://openalex.org/W2002948613","https://openalex.org/W2046784620","https://openalex.org/W2047241207","https://openalex.org/W2055465804","https://openalex.org/W2061331619","https://openalex.org/W2096271865","https://openalex.org/W2098708127","https://openalex.org/W2100554603","https://openalex.org/W2104175708","https://openalex.org/W2135689380","https://openalex.org/W2140606211","https://openalex.org/W2154849243","https://openalex.org/W2155124212","https://openalex.org/W2163878415","https://openalex.org/W2213696776","https://openalex.org/W2290987402","https://openalex.org/W2527103551","https://openalex.org/W2749222622","https://openalex.org/W2749602137","https://openalex.org/W2756227090","https://openalex.org/W2780530330","https://openalex.org/W2887988025","https://openalex.org/W2893793083","https://openalex.org/W2943289961","https://openalex.org/W2945429338","https://openalex.org/W2954197049","https://openalex.org/W2991428633","https://openalex.org/W3030944846","https://openalex.org/W3036956355","https://openalex.org/W3039300106","https://openalex.org/W3043299460","https://openalex.org/W4244847179"],"related_works":["https://openalex.org/W2290987402","https://openalex.org/W4365455149","https://openalex.org/W4385669757","https://openalex.org/W2188898607","https://openalex.org/W4385157130","https://openalex.org/W4391450096","https://openalex.org/W2104175708","https://openalex.org/W3165951146","https://openalex.org/W4386273902","https://openalex.org/W2915699780"],"abstract_inverted_index":{"BACKGROUND:":[0],"This":[1],"double-blind":[2],"(DB),":[3],"randomized,":[4],"parallel-group":[5],"study":[6],"was":[7,177,233],"designed":[8],"to":[9,21,69,96,235],"evaluate":[10],"efficacy":[11,199,225],"and":[12,41,100,115,148,215],"safety":[13,220],"of":[14,46,93,98,157,171,196,206,226,231,237],"paliperidone":[15,22,47],"palmitate":[16,23,48],"6-month":[17],"(PP6M)":[18],"formulation":[19,26],"relative":[20],"3-month":[24],"(PP3M)":[25],"in":[27,86,168,239,242],"patients":[28,34,65,107,129,172,243],"with":[29,244,248],"schizophrenia.":[30],"METHODS:":[31],"Following":[32],"screening,":[33],"entered":[35,111],"an":[36],"open-label":[37],"(OL)":[38],"maintenance":[39],"phase":[40,133],"received":[42],"1":[43],"injection":[44],"cycle":[45],"1-month":[49],"(PP1M;":[50],"100":[51],"or":[52,56,59,73,79,82,250],"150":[53],"mg":[54,61,75,84],"eq.)":[55,85],"PP3M":[57,80,216,238],"(350":[58,81],"525":[60,83],"eq.).":[62],"Clinically":[63],"stable":[64],"were":[66,102,108,121,142,210],"randomized":[67,122],"(2:1)":[68],"receive":[70],"PP6M":[71,94,213,232],"(700":[72],"1000":[74],"eq.,":[76],"gluteal":[77],"injections)":[78],"a":[87,227],"12-month":[88],"DB":[89,132],"phase;":[90],"2":[91],"doses":[92,97],"(corresponding":[95],"PP1M":[99,249],"PP3M)":[101,167],"chosen.":[103],"RESULTS:":[104],"Overall,":[105],"1036":[106],"screened,":[109],"838":[110],"the":[112,131,158,169,192,202],"OL":[113],"phase,":[114],"702":[116],"(mean":[117],"age:":[118],"40.8":[119],"years)":[120],"(PP6M:":[123,134],"478;":[124],"PP3M:":[125,137],"224);":[126],"618":[127],"(88.0%)":[128],"completed":[130],"416":[135],"[87.0%];":[136],"202":[138],"[90.2%]).":[139],"Relapse":[140],"rates":[141],"PP6M,":[143],"7.5%":[144],"(n":[145,151],"=":[146,152],"36)":[147],"PP3M,":[149],"4.9%":[150],"11).":[153],"The":[154,224],"Kaplan-Meier":[155],"estimate":[156],"difference":[159],"(95%":[160,185],"CI)":[161],"between":[162,212],"treatment":[163],"groups":[164],"(PP6M":[165],"-":[166],"percentages":[170],"who":[173],"remained":[174],"relapse":[175,241],"free":[176],"-2.9%":[178],"(-6.8%,":[179],"1.1%),":[180],"thus":[181],"meeting":[182],"noninferiority":[183,194],"criteria":[184],"CI":[186],"lower":[187],"bound":[188],"is":[189],"larger":[190],"than":[191],"pre-specified":[193],"margin":[195],"-10%).":[197],"Secondary":[198],"endpoints":[200],"corroborated":[201],"primary":[203],"analysis.":[204],"Incidences":[205],"treatment-emergent":[207],"adverse":[208],"events":[209],"similar":[211],"(62.1%)":[214],"(58.5%).":[217],"No":[218],"new":[219],"concerns":[221],"emerged.":[222],"CONCLUSIONS:":[223],"twice-yearly":[228],"dosing":[229],"regimen":[230],"noninferior":[234],"that":[236],"preventing":[240],"schizophrenia":[245],"adequately":[246],"treated":[247],"PP3M.":[251],"TRIAL":[252],"REGISTRATION:":[253],"Clinical":[254],"Trials.gov":[255],"identifier:":[256],"NCT03345342.":[257]},"counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":15},{"year":2023,"cited_by_count":26},{"year":2022,"cited_by_count":7}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2021-11-22T00:00:00"}